CL vs NRIX · P/E 34, rev $20.38B vs rev $54.5M
Colgate-Palmolive Company (CL) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
CL currently screens at market cap $70.88B and trailing P/E 34.3. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the CL and NRIX stock pages for the full models.
Not investment advice.